A Novel Method to Differentiate Tonsil-Derived Mesenchymal Stem Cells In Vitro into Estrogen-Secreting Cells
- Authors
- Kim, H.-Y.; Lee, Y.; Yoon, H.-S.; Kim, Y.-H.; Cho, K.-A.; Woo, S.-Y.; Kim, H.S.; Park, B.-Y.; Jung, S.-C.; Jo, I.; Park, W.-J.; Park, J.-W.; Ryu, K.-H.
- Issue Date
- Apr-2021
- Publisher
- Korean Tissue Engineering and Regenerative Medicine Society
- Keywords
- Cytochrome P450 family 19 subfamily A member 1; Estrogen; Mesenchymal stem cell; Secretion; Tonsil
- Citation
- Tissue Engineering and Regenerative Medicine, v.18, no.2, pp.253 - 264
- Journal Title
- Tissue Engineering and Regenerative Medicine
- Volume
- 18
- Number
- 2
- Start Page
- 253
- End Page
- 264
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/80659
- DOI
- 10.1007/s13770-020-00307-y
- ISSN
- 1738-2696
- Abstract
- BACKGROUND:: The advantages of tonsil-derived mesenchymal stem cells (TMSCs) over other mesenchymal stem cells (MSCs) include higher proliferation rates, various differentiation potentials, efficient immune-modulating capacity, and ease of obtainment. Specifically, TMSCs have been shown to differentiate into the endodermal lineage. Estrogen deficiency is a major cause of postmenopausal osteoporosis and is associated with higher incidences of ischemic heart disease and cerebrovascular attacks during the postmenopausal period. Therefore, stem cell-derived, estrogen-secreting cells might be used for estrogen deficiency. METHODS:: Here, we developed a novel method that utilizes retinoic acid, insulin-like growth factor-1, basic fibroblast growth factor, and dexamethasone to evaluate the differentiating potential of TMSCs into estrogen-secreting cells. The efficacy of the novel differentiating method for generation of estrogen-secreting cells was also evaluated with bone marrow- and adipose tissue-derived MSCs. RESULTS:: Incubating TMSCs in differentiating media induced the gene expression of cytochrome P450 19A1 (CYP19A1), which plays a key role in estrogen biosynthesis, and increased 17β-estradiol secretion upon testosterone addition. Furthermore, CYP11A1, CYP17A1, and 3β-hydroxysteroid dehydrogenase type-1 gene expression levels were significantly increased in TMSCs. In bone marrow-derived and adipose tissue-derived MSCs, this differentiation method also induced the gene expression of CYP19A1, but not CYP17A1, suggesting TMSCs are a superior source for estrogen secretion. CONCLUSION:: These results imply that TMSCs can differentiate into functional estrogen-secreting cells, thus providing a novel, alternative cell therapy for estrogen deficiency. © 2020, The Korean Tissue Engineering and Regenerative Medicine Society.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의예과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/80659)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.